Upbound Group, Inc. (UPBD) Balance Sheet
As of 2026-06-30 (10-Q), Upbound Group, Inc. (UPBD) reported total assets of $3.1B, total liabilities of $2.4B and shareholders' equity of $733.4M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $105.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
UPBDUpbound Group, Inc.Follow UPBD — free
—
Price chart with a free account
- Market cap
- 995.8M
- P/E TTM
- 11.1
- Dividend yield
- 9.1%
- 52-week
- —
- Next earnings
- 29 Oct, in 4 days
| Line | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.07 | 0.09 | 0.06 | 0.04 | 0.05 | 0.06 | 0.10 | 0.07 | 0.16 | 0.07 | 0.16 | 0.11 | 0.14 | 0.09 | 0.06 | 0.12 | 0.11 | |
| Total assets | 2.69 | 2.79 | 2.86 | 3.02 | 3.27 | 1.97 | 1.60 | 1.42 | 1.40 | 1.58 | 1.75 | 2.99 | 2.76 | 2.72 | 2.65 | 3.28 | 3.10 | |
| Long-term debt | 0.30 | 0.30 | 0.30 | 0.55 | 0.55 | 0.54 | 0.54 | 0.54 | 0.54 | — | — | — | — | — | — | — | — | |
| Total liabilities | 1.33 | 1.44 | 1.40 | 1.68 | 1.88 | 1.59 | 1.34 | 1.15 | 1.11 | 1.12 | 1.16 | 2.48 | 2.24 | 2.16 | 2.02 | 2.58 | 2.37 | |
| Shareholders' equity | 1.35 | 1.36 | 1.46 | 1.34 | 1.39 | 0.38 | 0.26 | 0.27 | 0.29 | 0.46 | 0.59 | 0.51 | 0.53 | 0.56 | 0.63 | 0.70 | 0.73 |
USD billions · SEC XBRL
Upbound Group, Inc. — questions
- How much cash does Upbound Group, Inc. have?
- $105.3M in cash and cash equivalents as of 2026-06-30.
- What are Upbound Group, Inc.'s total assets?
- $3.1B as of 2026-06-30.
- What is Upbound Group, Inc.'s shareholders' equity?
- $733.4M as of 2026-06-30.
Every figure on this page comes from Upbound Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.